top of page

Recent Posts

Experimental neuroblastoma drug shows promise in the lab

Jan 11, 2012

1 min read

Laboratory studies in the US have confirmed the promise of an experimental drug against a particularly aggressive form of neuroblastoma, the most common non-blood cancer in children.

Read more: http://info.cancerresearchuk.org/news/archive/cancernews/2012-01-05-Experimental-neuroblastoma-drug-shows-promise-in-the-lab

Trial provides first look at long-term outcomes of childhood immunotherapies

“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears

Largest study supports three courses of radiation for children with deadly brain tumor

Unraveling how a deadly childhood cancer spreads could keep it in its place

Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Archive

Search By Tags

bottom of page